Searchable abstracts of presentations at key conferences in endocrinology

ea0029p917 | Female Reproduction | ICEECE2012

Treatment of androgen excess in adolescent girls: ethinylestradiol–cyproteroneacetate vs low-dose pioglitazone–flutamide–metformin

Ibanez L. , Diaz M. , Rodriguez-Chacon M. , Maymo-Masip E. , Salvador C. , Lopez-Bermejo A. , Vendrell J. , de Zegher F.

Objective: To compare the effects of a classic therapy to those of a novel treatment for androgen excess in adolescent girls.Study design: Randomized, open-labeled trial over 12 months.Study participants: Adolescents (n=34; mean age 16 year, BMI 23 kg/m2) with hyperinsulinemic androgen excess and without risk of pregnancy.Interventions: Ethinyl estradiol-cyproterone acetate (EE-CA; Diane 35 ...